2026 Happy New Year, everyone!

Catch ONJCRI’s Dr Pavitha Parathan and Dr @davidyiju.bsky.social on @drshanerrr.bsky.social’s RRR program, Einstein A Go-Go this morning 📻 Talking bowel cancer and novel cancer treatment delivery systems 🔬 #sciencemedia #cancerresearch

ONJCRI researchers and collaborators at @unimelb.bsky.social and RMIT have developed a novel nanomedicine delivery system with highly ordered structures that enhance cargo delivery to their targets. ➡️ Read the paper: ow.ly/XmYX50X1j4I #LipidNanoparticles #Nanomedicine #CancerResearch

Excited to serve as a discussion leader this afternoon at the Cancer Nanotechnology Gordon Research Seminar in Italy! Looking forward to a great session of talks and discussion. www.grc.org/cancer-nanot... #GRC #CancerNanomedicine

📚 Congratulations to Dr Yi (David) Ju who received the Editorial Contribution Award and Author Service Award from ‪@springernature.com‬. These awards are a recognition of Dr Ju's contributions as an Editor for the Journal of Materials Science. #ONJCRI #ScientificJournal

Thrilled to see our Comment, “Balancing stealth and targeting to improve nanomedicine efficacy”, featured in the latest Nature Nanotechnology Editorial on PEGylation in nanomedicine. 📝 doi.org/10.1038/s415... 🗞️ doi.org/10.1038/s415...

Excited to speak at the Controlled Release Society (CRS) Local Chapter webinar on 21 May! ⏰ 8-10 AM UTC | 10 AM-12 PM CET | 6-8 PM AEST. My talk: From fundamental bio-nano interactions to mRNA vaccines & therapeutics. Free to join 👉Zoom Link: us06web.zoom.us/j/81945385019 Meeting ID: 819 4538 5019

📄 Thrilled! First paper from our new Nanomedicine & Gene Therapeutics Lab @onjcri.org.au just dropped in Nature Nanotechnology. We unpack the #stealth vs #targeting trade‑off—keeping nanoparticles invisible to immunity yet laser‑guiding them to diseased cells.

I'm thrilled to share that I have received an National Health and Medical Research Council (NHMRC) Investigator Grant! This fellowship will support me in developing next-generation mRNA therapeutics for cancer over the next five years. Thank you to everyone who has supported me on this journey!

⭐ ONJCRI is thrilled to welcome @davidyiju.bsky.social and the Nanomedicine & Gene Therapeutics Laboratory, a new hub for pioneering cancer research focusing on delivering mRNA therapeutics using advanced nanotechnology. 🧬 Read more about Dr Ju's Lab: ow.ly/i9l350UZ5ie

Today is my last day at RMIT—a heartfelt thank you to my mentors, colleagues, students, and friends for your support and collaboration. Excited to start as a Lab Head @onjcri.org.au next week, advancing cancer research. Looking forward to staying connected!

Thank you to the RMIT Media Team for promoting our research! It is exciting to see our work featured in over 60 news outlets, including US TV news (WGN in Chicago), MSN, Yahoo News, NetEase News and AOL, reaching a total audience of 86 million people. Read the story: www.rmit.edu.au/news/all-new...

I’m excited to share that I was recently interviewed on 2GB’s “Healthy Living” program, where I discussed our team’s latest research on person-specific nanomedicine targeting leukemia. 🎧 Listen to the full interview broadcast.meltwater.com/public-api/s...